[1]徐波,陆茵,吴家明,等.姜黄素抗肝纤维化分子机制研究进展[J].中国中医药信息杂志,2008,15(3):90-93.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):90-93.
点击复制

姜黄素抗肝纤维化分子机制研究进展

参考文献/References:

[1] Li D, Friedman SL. Liver fibrosis and the role of hepatic stellate cells[J]. J Gstroenterol Hepatol,1994,14:618.

[2] 程明亮,刘三都.肝纤维化的基础研究及临床[M].北京:人民卫生出版社,1995.17-50.

[3] 姜慧卿,张晓岚.肝纤维化的发生机制[J].世界华人消化杂志,2000,8 (6):681.

[4] 赵景润,舒建昌,沈 雁,等.姜黄素诱导肝星状细胞凋亡的初步研究[J]. Guangdong Medical Journal,2004,25(4):386-387.

[5] Xu J, Fu Y, Chen A. Activation of peroxisome proliferators- activated receptor-gamma contravutes to the inhititory effects of curcumin on hepatic stellate cell growth[J]. Am J Physiol Gastrointest Liver Physiol,2003,285(1):G20-30.

[6] 舒建昌,赵景润,杨冬华,等.姜黄素对肝星状细胞增殖与凋亡的影响[J].中华消化杂志,2004,24(5):282-284.

[7] 何雅军,舒建昌,吕霞等.姜黄素预防肝纤维化作用与肝星状细胞的关系[J].中华肝脏病杂志,2006,14(5):337-340.

[8] 杨伟峰,陈厚昌,李 琳.姜黄素对肝星状细胞增殖及分泌细胞外基质的影响[J]. Chin J Clini Hepatol,2004,20(3):142-143.

[9] 平 键,成 扬,徐列明,等.姜黄素激活PPARγ下调肝星状细胞α-SMA和Ⅰ型胶原的基因表达[J].中国中西医结合消化杂志,2006,14(4):215-218.

[10] 谢 明,廖晓宏,杨元盛,等.姜黄素对肝星状细胞株CTGF表达的影响[J].实用医学杂志,2006,22(15):1724-1726.

[11] Kang HC, Nan JX, Park PH, et al. Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro[J]. J Pharm Pharmacol,2002,54(1):119-126.

[12] Bruck R, Ashkenazi M, Weiss S, et al.Prevention of liver cirrhosis in rats by curcumin[J]. Liver Int,2007,27(3):373-383.

[13] Galli A, Crabb D, Price D, et al. Peroxisome proliferator- activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells[J]. Hepatology,2003,31(1):101-108.

[14] Galli A, Crabb DW, Ceni E, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro[J]. Gastroenterology,2002,122(7):1924-1940.

[15] 成 扬,平 键,徐列明,等.姜黄素上调PPARγ抑制肝星状细胞活化标志表达的研究[J].中国实用内科杂志,2006,26(24):1937-1940.

[16] Shizheng Zhong, Anping Chen. Activation of PPARγ is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro[J]. Biochem J,2004,384(pt1):149-157.

[17] Furukawa F, Matsuzaki K, Mori S, et al. P38 MAPK mediated fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts[J]. Hepatology,2003,38(4):879-889.

[18] Shizheng Zhong, Anping Chen. Disruption of transforming growth factor-β signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-γ in rat hepatic stellate cells[J]. Am J Physiol Gastrointest Liver Physiol,2007, 292(1):G113-123.

[19] Cheng Y, Ping J, Liu C, et al. Study on effects of extracts from Salvia Miltiorrhiza and Curcuma Longa in inhibiting phosphorylated[J]. Chin J Integr Med,2006,12(3):207-211.

[20] Park SD, Jung JH, Lee HW, et al. Zedoariae rhizoma and curcumin inhibits platelet-derived growth factor-induced proliferation of human hepatic myofibroblasts[J]. Int Immunopharmacol,2005, 5(3):555-569.

[21] Paradis V, Dargere D, Vidaud M, et al. Expression of connective tissue growth factor experimental rat and human liver fibrosis[J]. Hepatology,1999,30(4):968-976.

[22] Shizheng Zhong, Anping Chen. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor[J]. Am J Physiol Gastrointest Liver Physiol,2006, 290(5):G883-893.

[23] 刘永刚,陈厚昌,蒋毅萍.姜黄素对小鼠肝损伤的保护作用[J].中国中药杂志,2003,28(8):756-759.

[24] 刘永刚,陈厚昌,蒋毅萍.姜黄素抗肝纤维化的实验研究[J].时珍国医国药,2002,13(5):273-276.

[25] Park EJ, Jeon CH, Ko G, et al. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride[J]. J Pham Pharmacol,2000,52(4):437-440.

[26] 刘永刚,刘永忠,王晓东.姜黄素抗大鼠肝星状细胞氧应激脂质过氧化作用的研究[J].中成药,2004,26(10):829-832.

相似文献/References:

[1]张会存,李亚东,王继锋,等.姜黄素对人胚肺成纤维细胞转化生长因子 β受体的影响[J].中国中医药信息杂志,2010,17(12):23.[doi:10.3969/j.issn.1005-5304.2010.12.010]
 ZHANG Hui-cun,LI Ya-dong,WANG Ji-feng,et al.Effect of Curcumin on TGF-β Receptor of Human Embryo Lung Fibroblast[J].zhongguo zhongyiyao xinxi zazhi,2010,17(3):23.[doi:10.3969/j.issn.1005-5304.2010.12.010]
[2]李珊,蔡锐,伍参荣.加味四逆散对血吸虫病小鼠肝纤维化相关因子表达的影响[J].中国中医药信息杂志,2011,18(2):41.[doi:10.3969/j.issn.1005-5304.2011.02.017]
 LI Shan,CAI Rui,WU Can-rong.Effect of Modified Sini Powder on Expression of Liver Fibrosis Related Factors in Schistosomiasis Mice[J].zhongguo zhongyiyao xinxi zazhi,2011,18(3):41.[doi:10.3969/j.issn.1005-5304.2011.02.017]
[3]郭晓平.双虎清肝颗粒联合苦参素对乙型肝炎病毒感染后肝纤维化指标的干预作用[J].中国中医药信息杂志,2008,15(2):71.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):71.
[4]张丽娟,陆茵.姜黄素抗肿瘤机制研究进展[J].中国中医药信息杂志,2008,15(4):100.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):100.
[5]范荣国,王安莲.苦参素胶囊联合安络化纤丸防治慢性乙型肝炎肝纤维化临床观察[J].中国中医药信息杂志,2008,15(5):71.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):71.
[6]陈雁虹,秦波,张媛媛,等.姜黄素不同提取方法比较研究[J].中国中医药信息杂志,2008,15(7):55.
 CHEN Yan-hong,QIN Bo,ZHANG Yuan-yuan,et al.Comparative Study on the Process for Extration of Curcumin from Curcuma Longa L. with Different Methods[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):55.
[7]姚立,余静,李珏.丹参软肝饮对肝纤维化大鼠肝功能及肾素-血管紧张素-醛固酮系统的影响[J].中国中医药信息杂志,2011,18(4):34.[doi:10.3969/j.issn.1005-5304.2011.04.014]
 YAO Li,YU Jing,LI Jue.Influence of Danshen Ruangan Yin on Liver Fibrosis and RAAS of Rats[J].zhongguo zhongyiyao xinxi zazhi,2011,18(3):34.[doi:10.3969/j.issn.1005-5304.2011.04.014]
[8]刘江凯.百令胶囊治疗肝炎后肝纤维化临床观察[J].中国中医药信息杂志,2011,18(10):76.[doi:10.3969/j.issn.1005-5304.2011.10.033]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(3):76.[doi:10.3969/j.issn.1005-5304.2011.10.033]
[9]赵爱青,张晓明,侯恒,等.姜黄素与依那普利对单侧输尿管梗阻大鼠模型干预的对比研究[J].中国中医药信息杂志,2007,14(8):36.
 ZHAO Ai-qing,ZHANG Xiao-ming,HOU HENG,et al.Comparison Study between Curcumin and Enalapril Treatment in Unilateral Ureteral Obstruction Rats[J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):36.
[10]李晓杰,车景超.中药抗肝纤维化研究进展[J].中国中医药信息杂志,2007,14(9):94.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):94.

更新日期/Last Update: